GlassScriptPhysician profile
Erin K Kopeny
NPI 1053341743
$8,527.17
in general payments reported to CMS, 2019-2025
38 companies · $601 in 2025
The $601 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,581 · 2022: $3,378 · 2023: $1,156 · 2024: $811 · 2025: $601.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,568.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,568.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $1,500.10 | 2021-2022 | |
| Abbvie INC. | $1,287.88 | 2021-2025 | |
| Mayne Pharma Commercial LLC | $511.32 | 2021-2025 | |
| Novo Nordisk INC | $497.49 | 2021-2025 | Wegovy |
| Pfizer INC. | $470.60 | 2021-2025 | |
| Amneal Pharmaceuticals LLC | $399.34 | 2021-2024 | Unithroid |
| Therapeuticsmd, INC. | $381.68 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $353.03 | 2023-2025 | Myfembree, Gemtesa |
| Organon LLC | $271.93 | 2021-2025 | Nexplanon, Nuvaring |
| Agile Therapeutics, INC. | $267.99 | 2021-2023 | Twirla |
| Biohaven Pharmaceutical Holding Company LTD. | $231.00 | 2022 | |
| Exeltis, USA INC. | $209.48 | 2022-2025 | Slynd, Twirla |
| Hologic Sales and Service, LLC | $209.04 | 2023-2025 | Myosure Tissue Removal Device, Coolseal Generator, Thinprep 2000 Processor |
| Astellas Pharma US INC | $198.53 | 2021-2024 | Veozah |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $170.36 | 2021-2024 | Trulance, Xifaxan |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $158.80 | 2024-2025 | Zurzuvae |
| Lilly USA, LLC | $142.95 | 2021-2024 | Zepbound |
| Currax Pharmaceuticals LLC | $142.25 | 2021-2024 | Contrave |
| Amgen INC. | $133.75 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $122.09 | 2021 | |
| Aspira Women'S Health INC | $116.20 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $109.68 | 2021 | |
| Coopersurgical, INC. | $83.34 | 2022-2025 | Paragard T 380a, Summit Doppler |
| Radius Health, INC. | $79.70 | 2021-2023 | Tymlos |
| Shield Therapeutics INC | $78.30 | 2023-2024 | Accrufer |
| Becton, Dickinson and Company | $61.55 | 2021-2022 | |
| Exact Sciences Corporation | $56.00 | 2023-2024 | Cologuard Collection Kit |
| Alfasigma USA, INC. | $42.15 | 2021-2022 | |
| Avion Pharmaceuticals | $37.40 | 2021 | |
| Dexcom, INC. | $36.50 | 2025 | Dexcom G6 Transmitter |
| Ascend Therapeutics US, LLC | $28.96 | 2021-2022 | |
| Daiichi Sankyo INC. | $22.40 | 2022 | |
| Scynexis, INC. | $22.30 | 2022 | |
| Abbott Laboratories | $22.25 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.34 | 2023 | |
| Millicent US INC | $19.65 | 2025 | Femlyv |
| Ironwood Pharmaceuticals, INC | $17.40 | 2021 | |
| Ibsa Pharma INC. | $13.44 | 2024 | Tirosint, Licart |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Kopeny listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.